GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sino Biological Inc (SZSE:301047) » Definitions » EV-to-EBITDA

Sino Biological (SZSE:301047) EV-to-EBITDA : 14.63 (As of Apr. 25, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Sino Biological EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Sino Biological's enterprise value is ¥4,266.0 Mil. Sino Biological's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was ¥291.7 Mil. Therefore, Sino Biological's EV-to-EBITDA for today is 14.63.

The historical rank and industry rank for Sino Biological's EV-to-EBITDA or its related term are showing as below:

SZSE:301047' s EV-to-EBITDA Range Over the Past 10 Years
Min: 2.98   Med: 15.7   Max: 32.77
Current: 14.63

During the past 7 years, the highest EV-to-EBITDA of Sino Biological was 32.77. The lowest was 2.98. And the median was 15.70.

SZSE:301047's EV-to-EBITDA is ranked worse than
62.16% of 473 companies
in the Biotechnology industry
Industry Median: 9.22 vs SZSE:301047: 14.63

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-04-25), Sino Biological's stock price is ¥69.85. Sino Biological's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was ¥2.013. Therefore, Sino Biological's PE Ratio for today is 34.70.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Sino Biological EV-to-EBITDA Historical Data

The historical data trend for Sino Biological's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sino Biological EV-to-EBITDA Chart

Sino Biological Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial - - 19.51 18.64 16.27

Sino Biological Quarterly Data
Dec17 Dec18 Jun19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.64 25.59 23.22 26.04 16.27

Competitive Comparison of Sino Biological's EV-to-EBITDA

For the Biotechnology subindustry, Sino Biological's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sino Biological's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sino Biological's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Sino Biological's EV-to-EBITDA falls into.



Sino Biological EV-to-EBITDA Calculation

Sino Biological's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=4266.031/291.677
=14.63

Sino Biological's current Enterprise Value is ¥4,266.0 Mil.
Sino Biological's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥291.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sino Biological  (SZSE:301047) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Sino Biological's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=69.85/2.013
=34.70

Sino Biological's share price for today is ¥69.85.
Sino Biological's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥2.013.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Sino Biological EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Sino Biological's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Sino Biological (SZSE:301047) Business Description

Traded in Other Exchanges
N/A
Address
No. 18 Kechuang 10th Street, Room 306, Building 9, Beijing Economic and Technological Development Zon, Beijing, CHN, 100176
Sino Biological Inc is an international reagent supplier and service provider. The company specializes in recombinant protein production and antibody development. All of Sino Biological's products are independently developed and produced, including recombinant proteins, antibodies and cDNA clones.

Sino Biological (SZSE:301047) Headlines

No Headlines